Public Health Emergency - Leading a Nation Prepared
The Special Projects for Equitable and Efficient Distribution (SPEED) program is focused on increasing the availability of COVID-19 outpatient therapeutics (monoclonal antibody therapeutics [mAbs]) to vulnerable and underserved populations. Prioritizing long-term care facilities (LTCF), dialysis centers, federally qualified health centers (FQHCs), and correctional facilities, SPEED helps interested sites assess their readiness to administer mAbs.
Monoclonal antibody treatments, which are available under FDA’s Emergency Use Authorization, have been shown to reduce hospitalization and symptom days in
certain adult and pediatric high-risk COVID-19 positive individuals with mild to moderate symptoms. Your eligible patients who have had mild to moderate symptoms for 10 days or less may benefit from treatment with certain monoclonal antibody drugs.
SPEED began as a program to allocate and distribute mAbs to underserved communities during the time that monoclonal antibody therapeutics were available through allocation. SPEED formed partnerships with leaders and professional organizations associated with each of the provider types to help get mAbs to people in those communities more quickly.
In just a few months, SPEED had allocated nearly 30,000 patient courses to almost 1,000 priority settings across 49 states. To accomplish this, SPEED worked with 24 FQHCs representing more than 350 sites, over 1,000 dialysis centers, 172 home infusion providers 521 long-term care pharmacies, and 80 correctional facilities.
Now that allocation has ended, providers can work through the
direct order process, so SPEED is no longer playing a role in directly allocating products to facilities in underserved communities.
In the battle against COVID-19, SPEED will continue to champion equitable access and utilization of mAbs, including the continuation of engagements with existing partners and sites, identification of new partners that represent other vulnerable and underserved populations, collaboration with other Federal partners, and work with the COVID-19 Health Equity Task Force.
There are many factors to consider when choosing to administer mAbs. If your site is interested in administering these products to improve the health of the communities you serve, select your individual facility type to learn about planning considerations, ordering, tracking, seeking reimbursement, and more. You can also reach out to SPEED partners in the professional associations you partner with on a regular basis.
Long-term Care Facilities (LTCF)
Federally Qualified Health Centers
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages